Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Astellas' new company RSV Corp. gets RSV virosome vaccine from Mymetics

Executive Summary

Newly created RSV Corp. (RSVC) received exclusive worldwide rights to infectious disease vaccine developer Mymetics Corp.’s preclinical respiratory syncytial virus (RSV) vaccine.
Deal Industry
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R+D and Marketing-Licensing
    • Includes Contract
    • Intra-Biotech Deal

Related Companies

UsernamePublicRestriction

Register